SynthesisFrontiers in cardiovascular medicine2022

Fibroblast growth factor-23 and the risk of cardiovascular diseases and mortality in the general population: A systematic review and dose-response meta-analysis.

Menglu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.